Autologous Stem Cell Transplantation (ASCT) for Refractory Juvenile-Onset Systemic Sclerosis (jSSc) Is Safe and Well Tolerated and Improves Clinical and Patient-Reported Outcomes

Jessie L. Barnum, Paul Szabolcs, Kathryn S. Torok et al.|Blood|2022

Cited by 2